1. Improving Surgical Outcomes

2. Program Objective

3. Strategies for Minimizing Risk of Postoperative Residual NMB

4. EMG

5. Mechanomyography

6. Kinemyography

7. AMG

8. Benefits of EMG Monitoring

9. Case Example: PNS vs AMG

10. Assessment at End of Operation

11. Visual and Tactile Detection of Fade

12. Assessment After 10 Minutes

13. Assessment After Reversal Agent Is Administered

14. Potential CREs With Residual NMB

15. Incidence of CREs

16. Administration of Anticholinesterase NMB Reversal Agents

17. Consensus Statement on Perioperative Use of Neuromuscular Monitoring

18. Benefit of Easy-to-Use Objective Monitors

19. Clinical Effect of Objective Monitoring

20. Neostigmine

21. Dosing of Neostigmine

22. Time to NMB Reversal With Neostigmine

23. Potential Respiratory Complications With Inappropriate Neostigmine Administration

24. Sugammadex

25. NMB Reversal With Sugammadex vs Neostigmine

26. Dosing of Sugammadex

27. Conclusions

28. Abbreviations